Morphine induces hyperalgesia without involvement of μ-opioid receptor or morphine-3-glucuronide

Molecular Medicine

Volumn 18, Issue 9, 2012, Pages 1320-1326

  Swartjes, Maarten ^a   Mooren, René A G ^a   Waxman, Amanda R ^b,c   Arout, Caroline ^b,c   van de Wetering, Koen ^d   den Hartigh, Jan ^a   Beijnen, Jos H ^e   Kest, Benjamin ^b,c   Dahan, Albert ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; MORPHINE 3 GLUCURONIDE; MU OPIATE RECEPTOR; MULTIDRUG RESISTANCE PROTEIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; HYPERALGESIA; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PHARMACODYNAMICS; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL;

ANIMALS; HYPERALGESIA; MALE; MICE; MORPHINE; MORPHINE DERIVATIVES; NALTREXONE; REACTION TIME; RECEPTORS, OPIOID, MU;

EID: 84870315796     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2012.00244     Document Type: Article

References (32)

1. Ballantyne JC, Mao J. (2003) Opioid therapy for chronic pain. N. Engl. J. Med. 349:1943-53.
2. Angst MS, Clark JD. (2006) Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 104:570-87.
3. van Elstraete AC, Sitbon P, Trabold F, Mazoit X, Benhamou D. (2005) A single dose of intrathecal morphine induces long-lasting hyperalgesia: the protective effect of prior administration of ketamine. Anesth. Analg. 101:1750-6.
4. Yaksh TL, Harty GJ, Onofrio BM. (1986) High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications. Anesthesiology. 64:590-7.
5. Christrup LL. (1997) Morphine metabolites. Acta Anaesthesiol. Scand. 41:116-22.
6. Sarton E, et al. (2000) Sex differences in morphine analgesia: an experimental study in healthy volunteers. Anesthesiology. 93:1245-54.
7. Lötsch J. (2009) Pleiotropic effects of morphine-66-glucuronide. Anesthesiology. 110:1209-10.
8. Bartlett SE, Cramond T, Smith MT. (1994) The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex. Life Sci. 54:687-94.
9. Labella FS, Pinsky C, Havlicek V. (1979) Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity. Brain Res. 174:263-71.
10. Gong QL, Hedner J, Bjorkman R, Hedner T. (1992) Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain. 48:249-55.
11. Woolf CJ. (1981) Intrathecal high dose morphine produces hyperalgesia in the rat. Brain Res. 209:491-5.
12. Yaksh TL, Harty GJ, Onofrio BM. (1986) High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications. Anesthesiology. 64:590-7.
13. Dennis GC, et al. (1999). Analgesic responses to intrathecal morphine in relation to CSF concentrations of morphine-3, o-glucuronide and morphine-6,6-glucuronide. Life Sci. 64:1725-31.
14. Lipkowski AW, Carr DB, Langlade A, Osgood PF, Szyfelbein SK. (1994) Morphine-3-glucuronide: silent regulator of morphine actions. Life Sci. 55:149-54.
15. Ekblom M, Gardmark M, Hammarlund-Udenaes M. (1993) Pharmacokinetics and pharmacodynamics of morphine-3-glucuronide in rats and its influence on the antinociceptive effect of morphine. Biopharm. Drug Disp. 14:1-11.
16. Juni A, Klein G, Kest B. (2006) Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems. Brain Res. 1070:35-44.
17. Juni A, Klein G, Pintar JE, Kest B. (2007) Nociception increases during opioid infusion in opioid receptor triple knock-out mice. Neuroscience. 147:439-44.
18. Juni A, Klein G, Kowalczyk B, Ragnauth A, Kest B. (2008) Sex differences in hyperalgesia during morphine infusion: effect of gonadectomy and estrogen treatment. Neuropharmacology. 54:1264-70.
19. van Dorp E, et al. (2009) Morphine-6(-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans. Anesthesiology. 110:1356-63.
20. Zelcer N, et al. (2005) Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and decreased antinociception by morphine-6-glucuronide. Proc. Natl. Acad. Sci. U. S. A. 102:7274-9.
21. Zimmermann M. (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:109-10.
22. Swartjes M, Morariu A, Niesters M, Aarts L, Dahan A. (2011) Non-selective and NR2B-selective NMDA receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain. Anesthesiology. 115:165-74.
23. Rook EJ, Hillebrand MJX, Rosing H, van Ree JM, Beijnen JH. (2004) The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by highperformance liquid chromatography coupled with tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 824:213-21.
24. Wang X, et al. (2012) Morphine activates neuroinflammation in a manner parallel to endotoxin. Proc. Natl. Acad. Sci. U. S. A. 109:6325-30.
25. Hutchinson MR, et al. (2010) Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav. Immun. 24:83-95.
26. Waxman AR, Arout C, Caldwell M, Dahan A, Kest B. (2009) Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice. Neurosci. Lett. 462:68-72.
27. Antonilli L, Petecchia E, Capriolo D, Badiani A, Nencini P. (2005) Effect of repeated administrations of heroin, naltrexone, methadone, and alcohol on morphine glucuronidation in the rat. Psychopharmacology. 182:58-64.
28. Wahlström A, Winblad B, Bixo M, Rane A. (1988) Human brain metabolism of morphine and naloxone. Pain. 35:121-7.
29. Chizh BA. (2007) Low dose ketamine: a therapeutic and research tool to explore N-methyl-Daspartate (NMDA) receptor-mediated plasticity in pain pathways. J. Psychopharmacol. 21:259-71.
30. Sigtermans M, et al. (2009) Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. Pain. 145:304-11.
31. Sánchez-Blázquez P, Rodríguez-Muñoz M, Garzón J. (2010) Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDARCaMKII signaling. PLoS One. 5:311278.
32. Hemstapat K, Monteith GR, Smith D, Smith MT. (2003) Morphine-3-glucuronide's neuro-excitatory effects are mediated via indirect activation of N-methyl-D-aspartic acid receptors: mechanistic studies in embryonic cultured hippocampal neurons. Anesth. Analg. 97:494-505.